Lisata Therapeutics Ownership | Who Owns Lisata Therapeutics?


OverviewRevenueFinancialsChartTranscripts

Lisata Therapeutics Ownership Summary


Lisata Therapeutics is owned by 9.09% institutional investors, 19.82% insiders, and 71.09% retail investors. Bml capital management is the largest institutional shareholder, holding 2.44% of LSTA shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.22% of its assets in Lisata Therapeutics shares.

LSTA Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockLisata Therapeutics9.09%19.82%71.09%
SectorHealthcare Stocks 488.17%11.08%-399.26%
IndustryBiotech Stocks 306.59%11.10%-217.69%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Bml capital management209.81K2.44%$608.27K
Blackrock funding, inc. /de54.86K0.64%$159.04K
Cerity partners12.18K0.14%$32.29K
Founders capital management2.00K0.02%$5.80K
Raymond james financial6.000.00%$17.00
Wells fargo & company/mn---
Jpmorgan chase---
Cheviot value management3.00-$8.00
Loring wolcott & coolidge fiduciary advisors llp/ma---

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Bml capital management209.81K0.46%$608.27K
Founders capital management2.00K0.00%$5.80K
Cerity partners12.18K0.00%$32.29K
Jpmorgan chase---
Wells fargo & company/mn---
Blackrock funding, inc. /de54.86K-$159.04K
Raymond james financial6.00-$17.00
Loring wolcott & coolidge fiduciary advisors llp/ma---
Cheviot value management3.00-$8.00

Top Buyers

HolderShares% AssetsChange
Cerity partners12.18K0.00%12.18K
Raymond james financial6.00-6.00
Founders capital management2.00K0.00%-
Cheviot value management3.00--
Blackrock funding, inc. /de54.86K--

Top Sellers

HolderShares% AssetsChange
Bml capital management209.81K0.46%-7.04K
Jpmorgan chase---13.00
Loring wolcott & coolidge fiduciary advisors llp/ma---2.00
Wells fargo & company/mn---1.00
Cheviot value management3.00--

New Positions

HolderShares% AssetsChangeValue
Cerity partners12.18K0.00%12.18K$32.29K
Raymond james financial6.00-6.00$17.00

Sold Out

HolderChange
Wells fargo & company/mn-1.00
Loring wolcott & coolidge fiduciary advisors llp/ma-2.00
Jpmorgan chase-13.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Jun 30, 202520-9.09%782,490-0.11%910.96%8-20.00%3-40.00%
Mar 31, 20252215.79%783,376-0.29%910.23%1066.67%5150.00%
Dec 31, 202419-785,6782.42%911.10%6-25.00%2-50.00%
Sep 30, 202419-5.00%767,1241.97%911.24%8-11.11%4100.00%
Jun 30, 2024205.26%752,3101.84%911.42%9-52.63%2-

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Vanguard Total Stock Mkt Idx Inv191.37K2.22%-4.18K
Vanguard Institutional Extnd Mkt Idx Tr42.11K0.49%-15.48K
Fidelity Extended Market Index37.91K0.44%-99.00
Fidelity Series Total Market Index9.23K0.11%-
Northern Trust Extended Eq Market Idx7.14K0.08%-
NT Ext Equity Mkt Idx Fd - L7.14K0.08%-
Spartan Extended Market Index Pool F5.68K0.07%-
Fidelity Total Market Index4.38K0.05%-
Dimensional US Equity Market ETF3.85K0.04%-
DFA US Vector Equity I3.73K0.04%-

Recent Insider Transactions


DateNameRoleActivityValue
Dec 08, 2021MYERS STEVEN S-Buy$30.19K

Insider Transactions Trends


DateBuySell
2025 Q1--
2024 Q4--
2024 Q2--
2024 Q1--
2023 Q3--

LSTA Ownership FAQ


Who Owns Lisata Therapeutics?

Lisata Therapeutics shareholders are primarily institutional investors at 9.09%, followed by 19.82% insiders and 71.09% retail investors. The average institutional ownership in Lisata Therapeutics's industry, Biotech Stocks , is 306.59%, which Lisata Therapeutics falls below.

Who owns the most shares of Lisata Therapeutics?

Lisata Therapeutics’s largest shareholders are Bml capital management (209.81K shares, 2.44%), Blackrock funding, inc. /de (54.86K shares, 0.64%), and Cerity partners (12.18K shares, 0.14%). Together, they hold 3.22% of Lisata Therapeutics’s total shares outstanding.

Does Blackrock own Lisata Therapeutics?

BlackRock is not among the top 10 institutional shareholders of Lisata Therapeutics.

Who is Lisata Therapeutics’s biggest shareholder by percentage of total assets invested?

Bml capital management is Lisata Therapeutics’s biggest shareholder by percentage of total assets invested, with 0.46% of its assets in 209.81K Lisata Therapeutics shares, valued at 608.27K$.

Who is the top mutual fund holder of Lisata Therapeutics shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Lisata Therapeutics shares, with 2.22% of its total shares outstanding invested in 191.37K Lisata Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools